Yasuo Hozumi
Kasama, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 64 publications
Postoperative Adjuvant Anastrozole for 10 or 5 Years in Patients With Hormone Receptor-Positive Breast Cancer: AERAS, a Randomized Multicenter Open-Label Phase III Trial.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: April 20, 2023
Effect of early dose increase of evocalcet for intractable hypercalcemia caused by parathyroid carcinoma.
Journal: Endocrinology, diabetes & metabolism case reports
Published: April 08, 2022
A Case of Triple Cancer-A Patient Developed Malignant Lymphoma and Colon Cancer, during Breast Cancer Treatment
Journal: Gan to kagaku ryoho. Cancer & chemotherapy
Published: November 19, 2021
A Case of Triple-Negative Breast Cancer with Germline Pathogenic Variants in Both BRCA1 and BRCA2.
Journal: Case reports in oncology
Published: September 13, 2021
A Correlation Analysis Between Metabolism-related Genes and Treatment Response to S-1 as First-line Chemotherapy for Metastatic Breast Cancer: The SELECT BC-EURECA Study.
Journal: Clinical breast cancer
Published: October 15, 2020
Overestimation of Late Distant Recurrences in High-Risk Patients With ER-Positive Breast Cancer: Validity and Accuracy of the CTS5 Risk Score in the TEAM and IDEAL Trials.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: July 25, 2020
Invasive Cancer Confined to the Nipple of the Conserved Breast: A Case Report.
Journal: Case reports in oncology
Published: July 16, 2020
Distant Metastasis after Surgery for Encapsulated Papillary Carcinoma of the Breast: A Case Report.
Journal: Case reports in oncology
Published: July 16, 2020
The impact of neoadjuvant systemic therapy on breast conservation rates in patients with HER2-positive breast cancer: Surgical results from a phase II randomized controlled trial.
Journal: Surgical oncology
Published: May 15, 2020
Multi-omics analyses identify HSD17B4 methylation-silencing as a predictive and response marker of HER2-positive breast cancer to HER2-directed therapy.
Journal: Scientific reports
Published: March 21, 2020
Factors affecting enrollment in randomized controlled trials conducted for patients with metastatic breast cancer.
Journal: Japanese journal of clinical oncology
Published: February 02, 2020
Preoperative concurrent endocrine therapy with chemotherapy in luminal B-like breast cancer.
Journal: Breast cancer (Tokyo, Japan)
Published: January 08, 2020
Last Updated: 09/26/2026